Cleared Traditional

K983212 - ABBOTT ARCHITECT TESTOSTERONE (FDA 510(k) Clearance)

Nov 1998
Decision
65d
Days
Class 1
Risk

K983212 is an FDA 510(k) clearance for the ABBOTT ARCHITECT TESTOSTERONE. This device is classified as a Radioimmunoassay, Testosterones And Dihydrotestosterone (Class I - General Controls, product code CDZ).

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on November 18, 1998, 65 days after receiving the submission on September 14, 1998.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1680.

Submission Details

510(k) Number K983212 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 14, 1998
Decision Date November 18, 1998
Days to Decision 65 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code CDZ — Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class Class I - General Controls
CFR Regulation 21 CFR 862.1680